Role of matrix metalloproteinase-8 in atherosclerosis

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Lenglet, Sébastien ^a   MacH, François ^a   Montecucco, Fabrizio ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN E; C REACTIVE PROTEIN; CATHEPSIN G; CATHEPSIN K; CATHEPSIN L; CHYMOTRYPSIN; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGENASE 3; GELATINASE A; GELATINASE B; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; LOW DENSITY LIPOPROTEIN; MATRILYSIN; MATRIX METALLOPROTEINASE 26; MESSENGER RNA; NEUTROPHIL COLLAGENASE; STROMELYSIN; STROMELYSIN 2; STROMELYSIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE HEART INFARCTION; ALLELE; ANGIOCARDIOGRAPHY; ATHEROGENESIS; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; COLLAGEN DEGRADATION; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; ETHNICITY; EX VIVO STUDY; FOLLOW UP; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; IN VITRO STUDY; MACROPHAGE; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SMOOTH MUSCLE FIBER; STABLE ANGINA PECTORIS; ANIMAL; BLOOD; ENZYMOLOGY; GENETICS; METABOLISM; PATHOLOGY;

ANIMALS; ATHEROSCLEROSIS; HUMANS; MATRIX METALLOPROTEINASE 8;

EID: 84873337394     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/659282     Document Type: Review

References (54)

1. Baker A. H., Edwards D. R., Murphy G., Metalloproteinase inhibitors: biological actions and therapeutic opportunities. Journal of Cell Science 2002 115 19 3719 3727 2-s2.0-0036800192 10.1242/jcs.00063 (Pubitemid 35203598)
2. Lutgens E., Lutgens S. P. M., Faber B. C. G., Heeneman S., Gijbels M. M. J., De Winther M. P. J., Frederik P., Van Der Made I., Daugherty A., Sijbers A. M., Fisher A., Long C. J., Saftig P., Black D., Daemen M. J. A. P., Cleutjens K. B. J. M., Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation. Circulation 2006 113 1 98 107 2-s2.0-33644865170 10.1161/ CIRCULATIONAHA.105.561449 (Pubitemid 43958494)
3. Mahmood D. F., Jguirim-Souissi I., Khadija El.-H., Peroxisome proliferator-activated receptor gamma induces apoptosis and inhibits autophagy of human monocyte-derived macrophages via induction of cathepsin L: potential role in atherosclerosis. Journal of Biological Chemistry 2011 286 33 28858 28866
4. Galis Z. S., Sukhova G. K., Lark M. W., Libby P., Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. Journal of Clinical Investigation 1994 94 6 2493 2503 2-s2.0-0028063408 (Pubitemid 24379627)
5. Sukhova G. K., Schönbeck U., Rabkin E., Schoen F. J., Poole A. R., Billinghurst R. C., Libby P., Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 1999 99 19 2503 2509 2-s2.0-0345465669 (Pubitemid 29228279)
6. Hobeika M. J., Thompson R. W., Muhs B. E., Brooks P. C., Gagne P. J., Matrix metalloproteinases in peripheral vascular disease. Journal of Vascular Surgery 2007 45 4 849 857 2-s2.0-33947608239 10.1016/j.jvs.2006.09.066 (Pubitemid 46483940)
7. Brown D. L., Hibbs M. S., Kearney M., Isner J. M., Differential expression of 92-kDa gelatinase in primary atherosclerotic versus restenotic coronary lesions. American Journal of Cardiology 1997 79 7 878 882 2-s2.0-0031003372 10.1016/S0002-9149(97)00007-6 (Pubitemid 27197918)
8. Montecucco F., Di Marzo V., da Silva R. F., The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques. European Heart Journal 2012 33 7 846 856 10.1093/eurheartj/ehr449
9. Brown D. L., Hibbs M. S., Kearney M., Loushin C., Isner J. M., Identification of 92-kD gelatinase in human coronary atherosclerotic lesions: association of active enzyme synthesis with unstable angina. Circulation 1995 91 8 2125 2131 2-s2.0-0028906790
10. Jones C. B., Sane D. C., Herrington D. M., Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome. Cardiovascular Research 2003 59 4 812 823 2-s2.0-1642390201 10.1016/S0008-6363(03)00516-9 (Pubitemid 38366237)
11. Murphy G., Reynolds J. J., Bretz U., Baggiolini M., Partial purification of collagenase and gelatinase from human polymorphonuclear leucocytes. Analyses of their actions on soluble and insoluble collagens. Biochemical Journal 1982 203 1 209 221 2-s2.0-0020329185 (Pubitemid 12076046)
12. Hasty K. A., Jeffrey J. J., Hibbs M. S., Welgus H. G., The collagen substrate specificity of human neutrophil collagenase. Journal of Biological Chemistry 1987 262 21 10048 10052 2-s2.0-0023202438 (Pubitemid 17103059)
13. Knäuper V., Murphy G., Tschesche H., Activation of human neutrophil procollagenase by stromelysin 2. European Journal of Biochemistry 1996 235 1-2 187 191 2-s2.0-0030025404 (Pubitemid 26045433)
14. Hasty K. A., Pourmotabbed T. F., Goldberg G. I., Thompson J. P., Spinella D. G., Stevens R. M., Mainardi C. L., Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. Journal of Biological Chemistry 1990 265 20 11421 11424 2-s2.0-0025310828
15. Herman M. P., Sukhova G. K., Libby P., Gerdes N., Tang N., Horton D. B., Kilbride M., Breitbart R. E., Chun M., Schönbeck U., Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling. Circulation 2001 104 16 1899 1904 2-s2.0-0035899898 (Pubitemid 32983231)
16. Dollery C. M., Owen C. A., Sukhova G. K., Krettek A., Shapiro S. D., Libby P., Neutrophil elastase in human atherosclerotic plaques production by macrophages. Circulation 2003 107 22 2829 2836 2-s2.0-0037782348 10.1161/01.CIR.0000072792.65250.4A (Pubitemid 36705994)
17. Okada Y., Nakanishi I., Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 ('gelatinase') by human neutrophil elastase and cathepsin G. FEBS Letters 1989 249 2 353 356 2-s2.0-0024323967 (Pubitemid 19143491)
18. Itoh Y., Nagase H., Preferential inactivation of tissue inhibitor of metalloproteinase-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase. Journal of Biological Chemistry 1995 270 28 16518 16521 2-s2.0-0029019838 10.1074/jbc.270.28.16518
19. Ferry G., Lonchampt M., Pennel L., De Nanteuil G., Canet E., Tucker G. C., Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury. FEBS Letters 1997 402 2-3 111 115 2-s2.0-0031041367 10.1016/S0014-5793(96)01508-6 (Pubitemid 27078240)
20. Paulsson J., Dadfar E., Held C., Jacobson S. H., Lundahl J., Activation of peripheral and in vivo transmigrated neutrophils in patients with stable coronary artery disease. Atherosclerosis 2007 192 2 328 334 2-s2.0-34248188137 10.1016/j.atherosclerosis.2006.08.003 (Pubitemid 46726335)
21. Naruko T., Ueda M., Haze K., Van der Wal A. C., Van der Loos C. M., Itoh A., Komatsu R., Ikura Y., Ogami M., Shimada Y., Ehara S., Yoshiyama M., Takeuchi K., Yoshikawa J., Becker A. E., Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002 106 23 2894 2900 2-s2.0-0037016059 10.1161/01.CIR.0000042674.89762.20 (Pubitemid 35424738)
22. Dorweiler B., Torzewski M., Dahm M., Kirkpatrick C. J., Lackner K. J., Vahl C. F., Subendothelial infiltration of neutrophil granulocytes and liberation of matrix-destabilizing enzymes in an experimental model of human neo-intima. Thrombosis and Haemostasis 2008 99 2 373 381 2-s2.0-38949083926 10.1160/TH07-06-0387 (Pubitemid 351230969)
23. Molloy K. J., Thompson M. M., Jones J. L., Schwalbe E. C., Bell P. R. F., Naylor A. R., Loftus I. M., Unstable carotid plaques exhibit raised matrix metalloproteinase-8 activity. Circulation 2004 110 3 337 343 2-s2.0-3242691404 10.1161/01.CIR.0000135588.65188.14 (Pubitemid 38955503)
24. Nikkari S. T., O'Brien K. D., Ferguson M., Hatsukami T., Welgus H. G., Alpers C. E., Clowes A. W., Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation 1995 92 6 1393 1398 2-s2.0-0029164317
25. Sukhova G. K., Schönbeck U., Rabkin E., Schoen F. J., Poole A. R., Billinghurst R. C., Libby P., Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 1999 99 19 2503 2509 2-s2.0-0345465669 (Pubitemid 29228279)
26. Sluijter J. P. G., Pulskens W. P. C., Schoneveld A. H., Velema E., Strijder C. F., Moll F., De Vries J. P., Verheijen J., Hanemaaijer R., De Kleijn D. P. V., Pasterkamp G., Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms. Stroke 2006 37 1 235 239 2-s2.0-33644874476 10.1161/01.STR.0000196986.50059.e0 (Pubitemid 43732079)
27. Peeters W., Moll F. L., Vink A., Collagenase matrix metalloproteinase-8 expressed in atherosclerotic carotid plaques is associated with systemic cardiovascular outcome. European Heart Journal 2011 32 18 2314 2325 10.1093/eurheartj/ehq517
28. Laxton R. C., Hu Y., Duchene J., Zhang F., Zhang Z., Leung K. Y., Xiao Q., Scotland R. S., Hodgkinson C. P., Smith K., Willeit J., López- Otín C., Simpson I. A., Kiechl S., Ahluwalia A., Xu Q., Ye S., A role of matrix metalloproteinase-8 in atherosclerosis. Circulation Research 2009 105 9 921 929 2-s2.0-70350702937 10.1161/CIRCRESAHA.109.200279
29. Van Lint P., Libert C., Matrix metalloproteinase-8: cleavage can be decisive. Cytokine and Growth Factor Reviews 2006 17 4 217 223 2-s2.0-33745829453 10.1016/j.cytogfr.2006.04.001 (Pubitemid 44038613)
30. Tummala P. E., Chen X. L., Sundell C. L., Laursen J. B., Hammes C. P., Alexander R. W., Harrison D. G., Medford R. M., Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: a potential link between the renin-angiotensin system and atherosclerosis. Circulation 1999 100 11 1223 1229 2-s2.0-0033554453 (Pubitemid 29426599)
31. Pueyo M. E., Gonzalez W., Nicoletti A., Savoie F., Arnal J. F., Michel J. B., Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor- B activation induced by intracellular oxidative stress. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 3 645 651 2-s2.0-0034060298 (Pubitemid 30151676)
32. Naghavi M., Libby P., Falk E., Casscells S. W., Litovsky S., Rumberger J., Badimon J. J., Stefanadis C., Moreno P., Pasterkamp G., Fayad Z., Stone P. H., Waxman S., Raggi P., Madjid M., Zarrabi A., Burke A., Yuan C., Fitzgerald P. J., Siscovick D. S., De Korte C. L., Aikawa M., Airaksinen K. E. J., Assmann G., Becker C. R., Chesebro J. H., Farb A., Galis Z. S., Jackson C., Jang I. K., Koenig W., Lodder R. A., March K., Demirovic J., Navab M., Priori S. G., Rekhter M. D., Bahr R., Grundy S. M., Mehran R., Colombo A., Boerwinkle E., Ballantyne C., Insull W., Schwartz R. S., Vogel R., Serruys P. W., Hansson G. K., Faxon D. P., Kaul S., Drexler H., Greenland P., Muller J. E., Virmani R., Ridker P. M., Zipes D. P., Shah P. K., Willerson J. T., From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies-part I. Circulation 2003 108 14 1664 1672 2-s2.0-0141885294 10.1161/01.CIR.0000087480. 94275.97 (Pubitemid 37243650)
33. Naghavi M., Libby P., Falk E., Casscells S. W., Litovsky S., Rumberger J., Badimon J. J., Stefanadis C., Moreno P., Pasterkamp G., Fayad Z., Stone P. H., Waxman S., Raggi P., Madjid M., Zarrabi A., Burke A., Yuan C., Fitzgerald P. J., Siscovick D. S., De Korte C. L., Aikawa M., Airaksinen K. E. J., Assmann G., Becker C. R., Chesebro J. H., Farb A., Galis Z. S., Jackson C., Jang I. K., Koenig W., Lodder R. A., March K., Demirovic J., Navab M., Priori S. G., Rekhter M. D., Bahr R., Grundy S. M., Mehran R., Colombo A., Boerwinkle E., Ballantyne C., Insull W., Schwartz R. S., Vogel R., Serruys P. W., Hansson G. K., Faxon D. P., Kaul S., Drexler H., Greenland P., Muller J. E., Virmani R., Ridker P. M., Zipes D. P., Shah P. K., Willerson J. T., From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies-part II. Circulation 2003 108 15 1772 1778 2-s2.0-0142053972 10.1161/01.CIR.0000087481. 55887.C9 (Pubitemid 37296082)
34. Danesh J., Wheeler J. G., Hirschfield G. M., Eda S., Eiriksdottir G., Rumley A., Lowe G. D. O., Pepys M. B., Gudnason V., C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. The New England Journal of Medicine 2004 350 14 1387 1397 2-s2.0-1842587885 10.1056/NEJMoa032804 (Pubitemid 38419992)
35. Inokubo Y., Hanada H., Ishizaka H., Fukushi T., Kamada T., Okumura K., Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. American Heart Journal 2001 141 2 211 217 2-s2.0-0035147051 10.1067/mhj.2001.112238 (Pubitemid 32128725)
36. Tayebjee M. H., Lip G. Y. H., Tan K. T., Patel J. V., Hughes E. A., MacFadyen R. J., Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease. American Journal of Cardiology 2005 96 3 339 345 2-s2.0-23044482635 10.1016/j.amjcard.2005.03.072 (Pubitemid 41058855)
37. Taurino M., Raffa S., Mastroddi M., Visco V., Rizzo L., Torrisi M. R., Faraglia V., Metalloproteinase expression in carotid plaque and its correlation with plasma levels before and after carotid endarterectomy. Vascular and Endovascular Surgery 2008 41 6 516 521 2-s2.0-37249083624 10.1177/ 1538574407307405 (Pubitemid 350264712)
38. Zucker S., Hymowitz M., Conner C., Zarrabi H. M., Hurewitz A. N., Matrisian L., Boyd D., Nicolson G., Montana S., Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications. Annals of the New York Academy of Sciences 1999 878 212 227 2-s2.0-0032836427 10.1111/j.1749-6632.1999.tb07687. x (Pubitemid 29353573)
39. Turu M. M., Krupinski J., Catena E., Rosell A., Montaner J., Rubio F., Alvarez-Sabin J., Cairols M., Badimon L., Intraplaque MMP-8 levels are increased in asymptomatic patients with carotid plaque progression on ultrasound. Atherosclerosis 2006 187 1 161 169 2-s2.0-33744526254 10.1016/j.atherosclerosis. 2005.08.039 (Pubitemid 43817009)
40. Kato R., Momiyama Y., Ohmori R., Taniguchi H., Nakamura H., Ohsuzu F., Plasma matrix metalloproteinase-8 concentrations are associated with the presence and severity of coronary artery disease. Circulation Journal 2005 69 9 1035 1040 2-s2.0-27744591678 10.1253/circj.69.1035 (Pubitemid 41603087)
41. Momiyama Y., Ohmori R., Tanaka N., Kato R., Taniguchi H., Adachi T., Nakamura H., Ohsuzu F., High plasma levels of matrix metalloproteinase-8 in patients with unstable angina. Atherosclerosis 2010 209 1 206 210 2-s2.0-77049109629 10.1016/j.atherosclerosis.2009.07.037
42. Pussinen P. J., Sarna S., Puolakkainen M., Ohlin H., Sorsa T., Pesonen E., The balance of serum matrix metalloproteinase-8 and its tissue inhibitor in acute coronary syndrome and its recurrence. International Journal of Cardiology. In press 10.1016/j.ijcard.2011.12.095
43. Alfakry H., Sinisalo J., Paju S., The association of serum neutrophil markers and acute coronary syndrome. Scandinavian Journal of Immunology 2012 76 2 181 187 10.1111/j.1365-3083.2012.02718.x
44. Tuomainen A. M., Nyyssönen K., Laukkanen J. A., Tervahartiala T., Tuomainen T. P., Salonen J. T., Sorsa T., Pussinen P. J., Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 12 2722 2728 2-s2.0-36348991408 10.1161/ATVBAHA.107.154831 (Pubitemid 350158928)
45. Smith G. D., Ebrahim S., 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? International Journal of Epidemiology 2003 32 1 1 22 2-s2.0-0037322022 10.1093/ije/dyg070 (Pubitemid 36503465)
46. Zhang B., Ye S., Herrmann S. M., Eriksson P., De Maat M., Evans A., Arveiler D., Luc G., Cambien F., Hamsten A., Watkins H., Henney A. M., Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 1999 99 14 1788 1794 2-s2.0-0033551223 (Pubitemid 29181405)
47. Pearce E., Tregouet D. A., Samnegård A., Morgan A. R., Cox C., Hamsten A., Eriksson P., Ye S., Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction. Circulation Research 2005 97 10 1070 1076 2-s2.0-27944434274 10.1161/01.RES.0000189302.03303.11 (Pubitemid 41668921)
48. Abilleira S., Bevan S., Markus H. S., The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis. Journal of Medical Genetics 2006 43 12 897 901 2-s2.0-33846123302 10.1136/jmg.2006.040808 (Pubitemid 46080185)
49. Devarajan P., Mookhtiar K., Van Wart H., Berliner N., Structure and expression of the cDNA encoding human neutrophil collagenase. Blood 1991 77 12 2731 2738 2-s2.0-0025769518
50. Pendás A. M., Santamaría I., Alvarez M. V., Fine physical mapping of the human matrix metalloproteinase genes clustered on chromosome 11q22. 3. Genomics 1996 37 2 266 268 10.1006/geno.1996.0557 (Pubitemid 26360907)
51. Djurić T., Stanković A., Končar I., Association of MMP-8 promoter gene polymorphisms with carotid atherosclerosis: preliminary study. Atherosclerosis 2011 219 2 673 678 10.1016/j.atherosclerosis.2011.08.025
52. Wang H., Parry S., Macones G., Sammel M. D., Ferrand P. E., Kuivaniemi H., Tromp G., Halder I., Shriver M. D., Romero R., Strauss J. F., Functionally significant SNP MMP8 promoter haplotypes and preterm premature rupture of membranes (PPROM). Human Molecular Genetics 2004 13 21 2659 2669 2-s2.0-8444220043 10.1093/hmg/ddh287 (Pubitemid 39485414)
53. Lee J., Kim H. R., Min J. W., Jong S. P., Jin S. M., Sung K. H., Shim Y. S., Yim J. J., Lack of association between matrix metalloproteinase 8 promoter polymorphism and bronchiectasis in Koreans. Journal of Korean Medical Science 2007 22 4 667 671 2-s2.0-34548566932
54. Qiu W., Zhou G., Zhai Y., Zhang X., Xie W., Zhang H., Yang H., Zhi L., Yuan X., Zhang X., He F., No association of MMP-7, MMP-8, and MMP-21 polymorphisms with the risk of hepatocellular carcinoma in a Chinese population. Cancer Epidemiology Biomarkers and Prevention 2008 17 9 2514 2518 2-s2.0-53349127450 10.1158/1055-9965.EPI-08-0557